minimal Common Oncology Data Elements (mCODE) Implementation Guide
4.0.0 - STU4 United States of America flag

minimal Common Oncology Data Elements (mCODE) Implementation Guide, published by HL7 International / Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 4.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-mCODE-ig/ and changes regularly. See the Directory of published versions

: gx-genomics-report-adam-anyperson - JSON Representation

Raw json | Download

{
  "resourceType" : "DiagnosticReport",
  "id" : "gx-genomics-report-adam-anyperson",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-genomics-report"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: DiagnosticReport gx-genomics-report-adam-anyperson</b></p><a name=\"gx-genomics-report-adam-anyperson\"> </a><a name=\"hcgx-genomics-report-adam-anyperson\"> </a><a name=\"gx-genomics-report-adam-anyperson-en-US\"> </a><h2><span title=\"Codes:{http://loinc.org 51969-4}\">Genetic analysis report</span> (<span title=\"Codes:{http://terminology.hl7.org/CodeSystem/v2-0074 GE}\">Genetics</span>) </h2><table class=\"grid\"><tr><td>Subject</td><td>Adam Anyperson  Male, DoB: 1990-01-01 ( Medical Record Number: 123456789)</td></tr><tr><td>When For</td><td>2022-02-15 19:28:58+0500</td></tr><tr><td>Performer</td><td> <a href=\"Organization-gx-us-core-organization-gensop-inc.html\">Organization Gensop Labs, Inc.</a></td></tr></table><p><b>Report Details</b></p><table class=\"grid\"><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>Flags</b></td><td><b>When For</b></td></tr><tr><td><a href=\"Observation-gx-genomic-variant-somatic-bap1-indel.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9633-4}\">Present</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-variant-somatic-cdkn2a-cnv.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9633-4}\">Present</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-variant-somatic-cdkn2b-cnv.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9633-4}\">Present</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-variant-somatic-kdm5d.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9633-4}\">Present</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-variant-somatic-mtap.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9633-4}\">Present</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-variant-somatic-mycn.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9633-4}\">Present</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-variant-somatic-pof1b.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9633-4}\">Present</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-variant-somatic-polrmt.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9633-4}\">Present</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-diagnostic-implication-bap1.html\"><span title=\"Codes:{http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs diagnostic-implication}\">Diagnostic Implication</span></a></td><td/><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-diagnostic-implication-pof1b.html\"><span title=\"Codes:{http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs diagnostic-implication}\">Diagnostic Implication</span></a></td><td/><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-diagnostic-implication-polrmt.html\"><span title=\"Codes:{http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs diagnostic-implication}\">Diagnostic Implication</span></a></td><td/><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-variant-fusion-met-alk.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9633-4}\">Present</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-variant-pertinent-negative-nras-kit-braf.html\"><span title=\"Codes:{http://loinc.org 69548-6}\">Genetic variant assessment</span></a></td><td><span title=\"Codes:{http://loinc.org LA9634-2}\">Absent</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-tmb.html\"><span title=\"Codes:{http://loinc.org 94076-7}\">Mutations/Megabase [# Ratio] in Tumor</span></a></td><td>57.1 1/1000000{Base}<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM  code1/1000000{Base} = '1/1000000{Base}')</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-msi.html\"><span title=\"Codes:{http://loinc.org 81695-9}\">Microsatellite instability [Interpretation] in Cancer specimen Qualitative</span></a></td><td><span title=\"Codes:{http://loinc.org LA26203-2}\">MSI-H</span></td><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-therapeutic-implication-alectinib.html\"><span title=\"Codes:{http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}\">Therapeutic Implication</span></a></td><td/><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-therapeutic-implication-brigatinib.html\"><span title=\"Codes:{http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}\">Therapeutic Implication</span></a></td><td/><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-therapeutic-implication-ceritinib.html\"><span title=\"Codes:{http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}\">Therapeutic Implication</span></a></td><td/><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-therapeutic-implication-crizotinib.html\"><span title=\"Codes:{http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}\">Therapeutic Implication</span></a></td><td/><td>Final</td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-gx-genomic-therapeutic-implication-lorlatinib.html\"><span title=\"Codes:{http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}\">Therapeutic Implication</span></a></td><td/><td>Final</td><td>2019-04-01</td></tr></table></div>"
  },
  "basedOn" : [
    {
      🔗 "reference" : "ServiceRequest/gx-order-tumornormal-gensop-inc"
    }
  ],
  "status" : "final",
  "category" : [
    {
      "coding" : [
        {
          "system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
          "code" : "GE"
        }
      ]
    }
  ],
  "code" : {
    "coding" : [
      {
        "system" : "http://loinc.org",
        "code" : "51969-4",
        "display" : "Genetic analysis report"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/gx-cancer-patient-adam-anyperson"
  },
  "effectiveDateTime" : "2022-02-15T19:28:58+05:00",
  "performer" : [
    {
      🔗 "reference" : "Organization/gx-us-core-organization-gensop-inc"
    }
  ],
  "resultsInterpreter" : [
    {
      🔗 "reference" : "Practitioner/gx-practitioner-test-pathologist"
    }
  ],
  "specimen" : [
    {
      🔗 "reference" : "Specimen/gx-genomic-specimen-tumornormal-tumor"
    },
    {
      🔗 "reference" : "Specimen/gx-genomic-specimen-tumornormal-normal"
    }
  ],
  "result" : [
    {
      🔗 "reference" : "Observation/gx-genomic-variant-somatic-bap1-indel"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-variant-somatic-cdkn2a-cnv"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-variant-somatic-cdkn2b-cnv"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-variant-somatic-kdm5d"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-variant-somatic-mtap"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-variant-somatic-mycn"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-variant-somatic-pof1b"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-variant-somatic-polrmt"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-diagnostic-implication-bap1"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-diagnostic-implication-pof1b"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-diagnostic-implication-polrmt"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-variant-fusion-met-alk"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-variant-pertinent-negative-nras-kit-braf"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-tmb"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-msi"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-therapeutic-implication-alectinib"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-therapeutic-implication-brigatinib"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-therapeutic-implication-ceritinib"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-therapeutic-implication-crizotinib"
    },
    {
      🔗 "reference" : "Observation/gx-genomic-therapeutic-implication-lorlatinib"
    }
  ]
}